ISCHEMIC STROKE

Image

pRESET

ANEURYSM TREATMENT

ACCESS AND DELIVERY

INNOVATIONS

Image

HPC

Hydrophilic Polymer Coating

HPC is an aneurysm implant and Flow Diverter coating, which shall reduce the risk of thrombosis on the surface of stents. Due to the thrombogenic surface, platelet function-inhibiting drugs are needed to prevent in-stent thrombosis. The current solution of preventing platelet activation is the Dual Anti-Platelet Therapy (DAPT) consisting of Aspirin and Clopidogrel. HPC reduces the risk of thrombus formation on the implant by initially reducing or preventing the adhesion of platelets when in contact with blood. The whole implant is covered with an invisible coating.


For more information click here.

UPCOMING EVENTS

March

28MarAll Day29LINNC Americas 2022Miami, USA

April

13Apr(Apr 13)0:0014(Apr 14)0:00SLICE - NEXT FRONTIERS 2022SLICE - NEXT FRONTIERS - 100% OnlineOnline

24Apr(Apr 24)0:0029(Apr 29)23:59ABC WIN 2021 Anatomy-Biology-Clinical correlations - Working group in Interventional NeuroradiologyVal d'Isère - France

OUR TREATMENT SOLUTIONS

ANEURYSM TREATMENT

ISCHEMIC STROKE

ACCESS AND DELIVERY